Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × sargramostim × Clear all

NCT00466960 2017-08-28

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

Phase 2 Completed

21 enrolled 12 charts

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms

NCT00157573 2017-05-08

GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer

Phase 2 Completed

72 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00501644 2012-08-07

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Phase 2 Completed

59 enrolled 5 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms